Induction of multidrug resistance-associated protein 2 in liver, intestine and kidney of streptozotocin-induced diabetic rats

References

• Andersén E, Hellström P, Hellström K. (1987). Cholesterol biosynthesis in nonketotic diabetics before and during insulin therapy. Diabetes Res Clin Pract 3:207–214.
   PubMedGoogle Scholar
• Andersén E, Karlaganis G, Sjövall J. (1988). Altered bile acid profiles in duodenal bile and urine in diabetic subjects. Eur J Clin Invest 18:166–172.
   PubMed Web of Science ®Google Scholar
• Anger GJ, Magomedova L, Piquette-Miller M. (2009). Impact of acute streptozotocin-induced diabetes on ABC transporter expression in rats. Chem Biodivers 6:1943–1959.
   PubMedGoogle Scholar
• Barazzoni R, Zanetti M, Cappellari GG, Semolic A, Boschelle M, Codarin E, Pirulli A, Cattin L, Guarnieri G. (2011). Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. Diabetologia [Epub ahead of print].
   PubMedGoogle Scholar
• Benson AM, Barretto PB. (1985). Effects of disulfiram, diethyldithiocarbamate, bisethylxanthogen, and benzyl isothiocyanate on glutathione transferase activities in mouse organs. Cancer Res 45:4219–4223.
   PubMed Web of Science ®Google Scholar
• Boyer JL, Scheig RL, Klatskin G. (1970). The effect of sodium taurocholate on the hepatic metabolism of sulfobromophthalein sodium (BSP). The role of bile flow. J Clin Invest 49:206–215.
   PubMedGoogle Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Aleksunes LM, Manautou JE, Cherrington NJ, Scheffer GL, Yamasaki H, Slitt AL. (2008). Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm 5:77–91.
   PubMed Web of Science ®Google Scholar
• Cui Y, König J, Buchholz JK, Spring H, Leier I, Keppler D. (1999). Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55:929–937.
   PubMed Web of Science ®Google Scholar
• Dietrich CG, de Waart DR, Ottenhoff R, Bootsma AH, van Gennip AH, Elferink RP. (2001). Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo. Carcinogenesis 22:805–811.
   PubMed Web of Science ®Google Scholar
• Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, Groothuis GM. (2004). LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008–G1016.
   PubMed Web of Science ®Google Scholar
• Fardel O, Jigorel E, Le Vee M, Payen L. (2005). Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed Pharmacother 59:104–114.
   PubMed Web of Science ®Google Scholar
• Fukami M, Tanka A, Takikawa H. (2011). Effect of penicillin G on the biliary excretion of cholephilic compounds in rats. J Hepatobiliary Pancreat Sci 18:684–688.
   PubMedGoogle Scholar
• Garcia C, Feve B, Ferré P, Halimi S, Baizri H, Bordier L, Guiu G, Dupuy O, Bauduceau B, Mayaudon H. (2010). Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 36:327–338.
   PubMed Web of Science ®Google Scholar
• Goldberg RB. (2009). Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:3171–3182.
   PubMed Web of Science ®Google Scholar
• Hamaguchi K, Godwin AK, Yakushiji M, O’Dwyer PJ, Ozols RF, Hamilton TC. (1993). Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 53:5225–5232.
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Kishimoto S, Shibatani N, Inotsume N, Takeuchi Y, Fukushima S. (2010a). The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver. Biol Pharm Bull 33:153–156.
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Kishimoto S, Shibatani N, Nomura H, Ishii Y, Onishi M, Inotsume N, Takeuchi Y, Fukushima S. (2010b). The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver. J Pharm Pharmacol 62:310–314.
   PubMed Web of Science ®Google Scholar
• Hu N, Xie S, Liu L, Wang X, Pan X, Chen G, Zhang L, Liu H, Liu X, Liu X, Xie L, Wang G. (2011). Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats. Drug Metab Dispos 39:419–425.
   PubMed Web of Science ®Google Scholar
• Itagaki S, Sugawara M, Kobayashi M, Miyazaki K, Hirano T, Iseki K. (2004). Comparison of the disposition behavior of organic anions in an animal model for Wilson’s disease (Long-Evans Cinnamon rats) with that in normal Long-Evans Agouti rats. Drug Metab Pharmacokinet 19:150–154.
   PubMedGoogle Scholar
• Johnson BM, Zhang P, Schuetz JD, Brouwer KL. (2006). Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats. Drug Metab Dispos 34:556–562.
   PubMed Web of Science ®Google Scholar
• Kameyama N, Arisawa S, Ueyama J, Kagota S, Shinozuka K, Hattori A, Tatsumi Y, Hayashi H, Takagi K, Wakusawa S. (2008). Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. Biochim Biophys Acta 1782:355–360.
   PubMed Web of Science ®Google Scholar
• Kubitz R, Wettstein M, Warskulat U, Häussinger D. (1999). Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116:401–410.
   PubMed Web of Science ®Google Scholar
• Lischka K, Starke D, Failing K, Herling A, Kramer W, Petzinger E. (2003). Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides. Biochem Pharmacol 66:565–577.
   PubMed Web of Science ®Google Scholar
• Liu H, Xu X, Yang Z, Deng Y, Liu X, Xie L. (2006). Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res 1123:245–252.
   PubMed Web of Science ®Google Scholar
• Molino G, Cavanna A, Biondi AM, Macrì G, Urigu S, Ugazio G. (1982). Bromsulphalein (BSP) kinetics in the rat: a new approach in evaluating experimental hepatotoxicity. Int Arch Occup Environ Health 51:73–79.
   PubMedGoogle Scholar
• Mottino AD, Hoffman T, Jennes L, Vore M. (2000). Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther 293:717–723.
   PubMed Web of Science ®Google Scholar
• Nawa A, Fujita Hamabe W, Tokuyama S. (2010). Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions. Life Sci 86:402–409.
   PubMed Web of Science ®Google Scholar
• Ninomiya M, Ito K, Hiramatsu R, Horie T. (2006). Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2). Drug Metab Dispos 34:2056–2063.
   PubMed Web of Science ®Google Scholar
• Nomura M, Matsunami T, Kobayashi K, Uchibayashi T, Koshida K, Tanaka M, Namiki M, Mizuhara Y, Akiba T, Yokogawa K, Moritani S, Miyamoto K. (2005). Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin. Anticancer Res 25:2729–2735.
   PubMedGoogle Scholar
• Nowicki MT, Aleksunes LM, Sawant SP, Dnyanmote AV, Mehendale HM, Manautou JE. (2008). Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett 2:11–17.
   PubMedGoogle Scholar
• O’Máille ER, Richards TG, Short AH. (1966). Factors determining the maximal rate of organic anion secretion by the liver and further evidence on the hepatic site of action of the hormone secretin. J Physiol (Lond) 186:424–438.
   Google Scholar
• Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, Oude Elferink RP. (1999). Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338 (Pt 2):393–401.
   PubMedGoogle Scholar
• Paumgartner G, Horak W, Probst P, Grabner G. (1971). Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn Schmiedebergs Arch Pharmakol 270:98–101.
   PubMedGoogle Scholar
• Payen L, Sparfel L, Courtois A, Vernhet L, Guillouzo A, Fardel O. (2002). The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol Toxicol 18:221–233.
   PubMed Web of Science ®Google Scholar
• Reisman SA, Csanaky IL, Yeager RL, Klaassen CD. (2009). Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-transferase activity. Toxicol Sci 109:24–30.
   PubMedGoogle Scholar
• Saeki J, Sekine S, Horie T. (2011). LPS-induced dissociation of multidrug resistance-associated protein 2 (Mrp2) and radixin is associated with Mrp2 selective internalization in rats. Biochem Pharmacol 81:178–184.
   PubMedGoogle Scholar
• Schaub TP, Kartenbeck J, König J, Spring H, Dörsam J, Staehler G, Störkel S, Thon WF, Keppler D. (1999). Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10:1159–1169.
   PubMed Web of Science ®Google Scholar
• Schaub TP, Kartenbeck J, König J, Vogel O, Witzgall R, Kriz W, Keppler D. (1997). Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8:1213–1221.
   PubMed Web of Science ®Google Scholar
• Slitt AL, Cherrington NJ, Maher JM, Klaassen CD. (2003). Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab Dispos 31:1176–1186.
   PubMed Web of Science ®Google Scholar
• Stone JL, Braunstein JB, Beaty TM, Sanders RA, Watkins JB 3rd. (1997). Hepatobiliary excretion of bile acids and rose bengal in streptozotocin-induced and genetic diabetic rats. J Pharmacol Exp Ther 281:412–419.
   PubMedGoogle Scholar
• Suzuki H, Sugiyama Y. (2002). Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition. Adv Drug Deliv Rev 54:1311–1331.
   PubMed Web of Science ®Google Scholar
• Tamai M, Ito Y, Mirura H, Tsukada H, Yokogawa K, Nomura M, Moritani S, Miyamoto K. (2003). Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells. Anticancer Res 23:4781–4787.
   PubMed Web of Science ®Google Scholar
• Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL. (1997). The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113:255–264.
   PubMed Web of Science ®Google Scholar
• Van Aubel RA, Koenderink JB, Peters JG, Van Os CH, Russel FG. (1999). Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells. Mol Pharmacol 56:714–719.
   PubMed Web of Science ®Google Scholar
• Villanueva GR, Herreros M, Perez-Barriocanal F, Bolaños JP, Bravo P, Marin JJ. (1990). Enhancement of bile acid-induced biliary lipid secretion by streptozotocin in rats: role of insulin deficiency. J Lab Clin Med 115:441–448.
   PubMedGoogle Scholar
• Watkins JB 3rd, Sherman SE. (1992). Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. J Pharmacol Exp Ther 260:1337–1343.
   PubMedGoogle Scholar
• Yumoto R, Hamada S, Okada K, Kato Y, Ikehata M, Nagai J, Takano M. (2009). Effect of ursodeoxycholic acid treatment on the expression and function of multidrug resistance-associated protein 2 in rat intestine. J Pharm Sci 98:2822–2831.
   PubMedGoogle Scholar
• Zhang LL, Lu L, Jin S, Jing XY, Yao D, Hu N, Liu L, Duan R, Liu XD, Wang GJ, Xie L. (2011). Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats. Acta Pharmacol Sin 32:956–966.
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Fuchsbichler A, Silbert D, Wagner M, Arbeiter S, Gonzalez FJ, Marschall HU, Zatloukal K, Denk H, Trauner M. (2003). Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol 39:480–488.
   PubMed Web of Science ®Google Scholar